Advancing the science of patient input throughout the regulatory decision‐making process

The US Food and Drug Administration (FDA) understands the value of patient input in the regulatory decision‐making process and has worked to enhance meaningful engagement. In recent years, there has been an increased scientific demand for more systematic and quantitative approaches to incorporate pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tegenge, Million A., Moncur, Megan M., Sokolic, Robert, Forshee, Richard A., Irony, Telba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Experience Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508573/
https://www.ncbi.nlm.nih.gov/pubmed/31245564
http://dx.doi.org/10.1002/lrh2.10032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508573/
https://www.ncbi.nlm.nih.gov/pubmed/31245564
http://dx.doi.org/10.1002/lrh2.10032

Ejemplares similares